C Baudelet

Affiliations

Global Drug Development, Biometrics & Data Sciences, Bristol Myers Squibb, Princeton, USA.

Réseau de co-auteurs

Christine Baudelet 4 collaborations

Solange Peters 2 collaborations

Jerónimo Rodríguez-Cid 2 collaborations

Laurent Greillier 2 collaborations

Jennifer Sheng 1 collaboration

Jason Zhang 1 collaboration

Amit Roy 1 collaboration

Yi-Long Wu 1 collaboration

Shun Lu 1 collaboration

Ying Cheng 1 collaboration

Caicun Zhou 1 collaboration

Jie Wang 1 collaboration

Tony Mok 1 collaboration

Li Zhang 1 collaboration

Hai-Yan Tu 1 collaboration

Lin Wu 1 collaboration

Jifeng Feng 1 collaboration

Yiping Zhang 1 collaboration

Alexander Valerievich Luft 1 collaboration

Jianying Zhou 1 collaboration

Zhiyong Ma 1 collaboration

You Lu 1 collaboration

Chengping Hu 1 collaboration

Yuankai Shi 1 collaboration

Junliang Cai 1 collaboration

Jianhua Chang 1 collaboration

Taofeek K Owonikoko 1 collaboration

Keunchil Park 1 collaboration

Ramaswamy Govindan 1 collaboration

Neal Ready 1 collaboration

Martin Reck 1 collaboration

Shaker R Dakhil 1 collaboration

Alejandro Navarro 1 collaboration

Michael Schenker 1 collaboration

Jong-Seok Lee 1 collaboration

Vanesa Gutierrez 1 collaboration

Ivor Percent 1 collaboration

Daniel Morgensztern 1 collaboration

Carlos H Barrios 1 collaboration

Sofia Baka 1 collaboration

Miten Patel 1 collaboration

Wen Hong Lin 1 collaboration

Giovanni Selvaggi 1 collaboration

Jonathan Baden 1 collaboration

Dimple Pandya 1 collaboration

Parul Doshi 1 collaboration

Hye Ryun Kim 1 collaboration

D R Spigel 1 collaboration

D Vicente 1 collaboration

T E Ciuleanu 1 collaboration

S Gettinger 1 collaboration

S Peters 1 collaboration

L Horn 1 collaboration

C Audigier-Valette 1 collaboration

N Pardo Aranda 1 collaboration

O Juan-Vidal 1 collaboration

Y Cheng 1 collaboration

H Zhang 1 collaboration

M Shi 1 collaboration

A Luft 1 collaboration

J Wolf 1 collaboration

S Antonia 1 collaboration

K Nakagawa 1 collaboration

J Fairchild 1 collaboration

D Pandya 1 collaboration

P Doshi 1 collaboration

H Chang 1 collaboration

M Reck 1 collaboration

Paul Baas 1 collaboration

Arnaud Scherpereel 1 collaboration

Anna K Nowak 1 collaboration

Nobukazu Fujimoto 1 collaboration

Anne S Tsao 1 collaboration

Aaron S Mansfield 1 collaboration

Sanjay Popat 1 collaboration

Thierry Jahan 1 collaboration

Scott Antonia 1 collaboration

Youssef Oulkhouir 1 collaboration

Yolanda Bautista 1 collaboration

Robin Cornelissen 1 collaboration

Francesco Grossi 1 collaboration

Dariusz Kowalski 1 collaboration

Praveen Aanur 1 collaboration

Abderrahim Oukessou 1 collaboration

Gérard Zalcman 1 collaboration

C Baudelet

Affiliations

Publications (5)

Clinical Benefit-Risk Assessment of Nivolumab 240 mg Every 2 Weeks in Chinese Patients With Advanced and Metastatic Solid Tumors.

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial.

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.

Réseau de co-auteurs